Market Overview:
The global L-glutathione reduced market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for L-glutathione reduced in pharmaceutical, cosmetics, nutraceuticals, and food applications. Additionally, the growing awareness about the benefits of L-glutathione reduced is also contributing to the growth of this market. On the basis of type, the global L-glutathione reduced market can be segmented into injection type, medicinal tablet form, and other forms. The injection type segment is expected to account for a major share of this market during the forecast period owing to its high demand in pharmaceutical applications. On the basis of application, this market can be divided into pharmaceuticals; cosmetics; nutraceuticals; and food products. Pharmaceuticals are estimated to account for a major share of this market during 2018–2030 owing to their large population base and rising consumer awareness about health benefits associated with glutathione supplementation therapy.
Product Definition:
L-Glutathione Reduced is a supplement that is made up of the amino acids L-glutamine, L-cysteine, and glycine. It is used to improve athletic performance, increase energy levels, reduce muscle fatigue, and boost the immune system.
Injection Type:
Injection type is a method of drug delivery, which involves the administration of drugs in the form of injections. The most common injection types are insulin, vaccine, and vitamin. Injection type accounted for more than 50% market share globally in 2015 owing to its high usage rate coupled with rising awareness regarding better healthcare practices.
Medicinal Tablet:
L-glutathione (GSH) is a major antioxidant found in the human body. It helps in neutralizing free radicals that cause cell damage and are responsible for many diseases and disorders. GSH also acts as an anti-inflammatory agent by inhibiting the production of cytokines, which are substances produced by immune cells to communicate with other cells.
Application Insights:
The global market is segmented by application into pharmaceutical, nutraceutical, cosmetics and food. The pharmaceutical segment held the largest share in 2017. This is attributed to extensive usage of L-glutathione as a drug stabilizer and preservative for the manufacturing of drugs. It also plays an important role in maintaining health by acting as a antioxidant, which helps prevent cell damage caused due to oxidation process.
Glutathione reduces toxicity of heavy metals such as lead, copper and mercury on cells level by chelating their ions thereby preventing them from causing any harm to human body tissues or organs. These properties make it highly useful in various applications including water treatment & purification where it acts as an effective disinfectant and deodorizer owing to its sweetish odor when reduced glutathione comes in contact with air or water vapor containing sulfur compounds like hydrogen sulfide (H2S).
Regional Analysis:
North America accounted for the largest revenue share in 2017. Increasing prevalence of skin cancer and other skin diseases, such as eczema and psoriasis, is expected to boost demand for nutritional products over the forecast period. In addition, rising consumer awareness regarding health benefits associated with dietary supplements is anticipated to fuel regional product demand.
Asia Pacific market was valued at USD X million in 2017 owing to high consumption of alcohol which leads to liver damage leading to reduced level of glutathione in blood stream resulting into L-glutathione deficiency syndrome or GSD (Keloidosis). The condition may develop into a life-threatening emergency if not treated on time resulting into death due to multiple organ failure or acute respiratory distress syndrome among others (ADSS).
Growth Factors:
- Increasing awareness of the benefits of glutathione among consumers.
- Growing demand for natural and organic products.
- Rising popularity of anti-aging skin care products.
- Increased use of glutathione in medical applications.
- Growing interest in alternative therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
L-Glutathione Reduced Market Research Report
By Type
Injection Type, Medicinal Tablet, Other
By Application
Pharmaceutical, Cosmetics, Nutraceutical, Food
By Companies
Kyowa Hakko Bio Co. Ltd., Shandong Jincheng Biological Pharmaceutical Co. Ltd., KOHJIN Life Sciences Co. Ltd., Anhui GSH Bio-Technology Co. Ltd, Kaiping Genuine Biochemical Pharmaceutical Co. Ltd, Herbo Nutra, Haihang IndustryCo. Ltd., Meteoric Biopharmaceuticals Pvt. Ltd., Xi'an Fengzu Biological Technology Co. Ltd, YAOPHARMA, Cayman Chemical Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
206
Number of Tables & Figures
145
Customization Available
Yes, the report can be customized as per your need.
Global L-Glutathione Reduced Market Report Segments:
The global L-Glutathione Reduced market is segmented on the basis of:
Types
Injection Type, Medicinal Tablet, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical, Cosmetics, Nutraceutical, Food
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kyowa Hakko Bio Co. Ltd.
- Shandong Jincheng Biological Pharmaceutical Co. Ltd.
- KOHJIN Life Sciences Co. Ltd.
- Anhui GSH Bio-Technology Co. Ltd
- Kaiping Genuine Biochemical Pharmaceutical Co. Ltd
- Herbo Nutra
- Haihang IndustryCo. Ltd.
- Meteoric Biopharmaceuticals Pvt. Ltd.
- Xi'an Fengzu Biological Technology Co. Ltd
- YAOPHARMA
- Cayman Chemical Company
Highlights of The L-Glutathione Reduced Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection Type
- Medicinal Tablet
- Other
- By Application:
- Pharmaceutical
- Cosmetics
- Nutraceutical
- Food
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the L-Glutathione Reduced Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
L-Glutathione is reduced by the body when it is exposed to toxins and harmful chemicals.
Some of the key players operating in the l-glutathione reduced market are Kyowa Hakko Bio Co. Ltd., Shandong Jincheng Biological Pharmaceutical Co. Ltd., KOHJIN Life Sciences Co. Ltd., Anhui GSH Bio-Technology Co. Ltd, Kaiping Genuine Biochemical Pharmaceutical Co. Ltd, Herbo Nutra, Haihang IndustryCo. Ltd., Meteoric Biopharmaceuticals Pvt. Ltd., Xi'an Fengzu Biological Technology Co. Ltd, YAOPHARMA, Cayman Chemical Company.
The l-glutathione reduced market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 L-Glutathione Reduced Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 L-Glutathione Reduced Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 L-Glutathione Reduced Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the L-Glutathione Reduced Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global L-Glutathione Reduced Market Size & Forecast, 2018-2028
4.5.1 L-Glutathione Reduced Market Size and Y-o-Y Growth
4.5.2 L-Glutathione Reduced Market Absolute $ Opportunity
Chapter 5 Global L-Glutathione Reduced Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 L-Glutathione Reduced Market Size Forecast by Type
5.2.1 Injection Type
5.2.2 Medicinal Tablet
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global L-Glutathione Reduced Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 L-Glutathione Reduced Market Size Forecast by Applications
6.2.1 Pharmaceutical
6.2.2 Cosmetics
6.2.3 Nutraceutical
6.2.4 Food
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global L-Glutathione Reduced Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 L-Glutathione Reduced Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America L-Glutathione Reduced Analysis and Forecast
9.1 Introduction
9.2 North America L-Glutathione Reduced Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America L-Glutathione Reduced Market Size Forecast by Type
9.6.1 Injection Type
9.6.2 Medicinal Tablet
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America L-Glutathione Reduced Market Size Forecast by Applications
9.10.1 Pharmaceutical
9.10.2 Cosmetics
9.10.3 Nutraceutical
9.10.4 Food
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe L-Glutathione Reduced Analysis and Forecast
10.1 Introduction
10.2 Europe L-Glutathione Reduced Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe L-Glutathione Reduced Market Size Forecast by Type
10.6.1 Injection Type
10.6.2 Medicinal Tablet
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe L-Glutathione Reduced Market Size Forecast by Applications
10.10.1 Pharmaceutical
10.10.2 Cosmetics
10.10.3 Nutraceutical
10.10.4 Food
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific L-Glutathione Reduced Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific L-Glutathione Reduced Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific L-Glutathione Reduced Market Size Forecast by Type
11.6.1 Injection Type
11.6.2 Medicinal Tablet
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific L-Glutathione Reduced Market Size Forecast by Applications
11.10.1 Pharmaceutical
11.10.2 Cosmetics
11.10.3 Nutraceutical
11.10.4 Food
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America L-Glutathione Reduced Analysis and Forecast
12.1 Introduction
12.2 Latin America L-Glutathione Reduced Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America L-Glutathione Reduced Market Size Forecast by Type
12.6.1 Injection Type
12.6.2 Medicinal Tablet
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America L-Glutathione Reduced Market Size Forecast by Applications
12.10.1 Pharmaceutical
12.10.2 Cosmetics
12.10.3 Nutraceutical
12.10.4 Food
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) L-Glutathione Reduced Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) L-Glutathione Reduced Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) L-Glutathione Reduced Market Size Forecast by Type
13.6.1 Injection Type
13.6.2 Medicinal Tablet
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) L-Glutathione Reduced Market Size Forecast by Applications
13.10.1 Pharmaceutical
13.10.2 Cosmetics
13.10.3 Nutraceutical
13.10.4 Food
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 L-Glutathione Reduced Market: Competitive Dashboard
14.2 Global L-Glutathione Reduced Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Kyowa Hakko Bio Co. Ltd.
14.3.2 Shandong Jincheng Biological Pharmaceutical Co. Ltd.
14.3.3 KOHJIN Life Sciences Co. Ltd.
14.3.4 Anhui GSH Bio-Technology Co. Ltd
14.3.5 Kaiping Genuine Biochemical Pharmaceutical Co. Ltd
14.3.6 Herbo Nutra
14.3.7 Haihang IndustryCo. Ltd.
14.3.8 Meteoric Biopharmaceuticals Pvt. Ltd.
14.3.9 Xi'an Fengzu Biological Technology Co. Ltd
14.3.10 YAOPHARMA
14.3.11 Cayman Chemical Company
